SELECT LANGUAGE BELOW

Taurine in energy drinks could promote the growth of blood cancer, new study finds

Recent research suggests that common ingredients in certain foods and beverages might be linked to a higher risk of blood cancer. A study conducted by the Wilmott Cancer Institute at the University of Rochester in New York highlights how these elements can encourage the growth of leukemia cells, particularly those derived from non-essential amino acids that are naturally present in our bodies, including in bone marrow, brain, heart, and muscles.

These compounds are often found in meat, fish, eggs, energy drinks, and protein supplements.

Dr. Jeevisha Bajaj, an assistant professor of Biomedical Genetics involved in the study, emphasized the significance of taurine, stating that it can be utilized by leukemia cells to facilitate cancer growth. She expressed optimism about the potential for new strategies to prevent cancer cells from absorbing taurine, which could lead to better outcomes for leukemia patients.

The researchers stumbled upon their findings while focusing on bone marrow to enhance treatments for blood cancer. Dr. Bajaj noted, rather surprisingly, that they discovered taurine production in the bone marrow environment, an observation that had not been made in previous research.

Taurine seems to drive the cancerous growth in leukemia cells through glycolysis, a process that breaks down glucose for energy. This ability is particularly evident in types of leukemia that arise from blood stem cells in the bone marrow, such as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).

The study’s results were published in the journal Nature. Dr. Bajaj expressed excitement about the implications of their work, suggesting that targeting taurine uptake in leukemia cells could be a promising avenue for treating aggressive forms of the disease.

Moreover, the researchers acknowledged several limitations in their study. For instance, while they observed elevated taurine levels in the bone marrow of leukemia-affected mice, there was no evidence of similar levels in humans with acute myeloid leukemia—a point Dr. Bajaj is keen on exploring further.

The team also plans to delve into how myelodysplastic syndromes may predispose individuals to acute leukemia in the future.

Given these findings, the researchers recommend that leukemia patients evaluate the inclusion of taurine-rich foods and supplements in their diets, but with guidance from their healthcare providers. They raised intriguing points about taurine being a prevalent ingredient in energy drinks and considered the implications of its role while discussing possible chemotherapeutic benefits.

Dr. Marc Siegel, a senior medical analyst, shared his thoughts on the study, highlighting potential concerns regarding high taurine levels in energy drinks and their possible influence on leukemia cells. He noted that leukemia cells in bone marrow rely on taurine, which is not synthesized by the body.

Siegel urges further research to clarify how to inhibit taurine uptake in leukemia cells. While this is preliminary, he believes it uncovers a crucial connection between dietary choices and cancer risks.

Experts have also voiced concerns over popular energy drinks containing taurine, suggesting that excessive consumption might not be ideal. They generally recommend steering clear of energy beverages filled with synthetic additives, pointing out that many of these products contain a multitude of ingredients that are not easily recognizable.

In short, being cautious about the intake of energy drinks and understanding their contents could be more important than we realize.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News